Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Smaller particles of the drug carrier penetrated skin better, with 300 nm size being best for targeting hair follicles.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

The PW91 method is best for calculating the basic physical and chemical properties of Finasteride, a drug used for prostate issues and hair loss.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

El acetato de ciproterona trata problemas androgénicos como hirsutismo, acné, seborrea y alopecia con diferentes dosis y combinaciones.

A teenager's hair loss was caused by the drug quetiapine but improved after stopping the medication.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Mixed coconut oil/solvent is suitable for cyproterone acetate injections, but more safety checks are needed.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The FDA did not approve a testosterone drug because of safety concerns.